Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 45 results.
User Information
Export Records
  1. 1.   Benzyl Ammonium Carbamates Undergo Two-Step Linker Cleavage and Improve the Properties of Antibody Conjugates
  2. Li,Xiaoyi; Patel,Nimit; Kalen,Joseph; Schnermann,Martin
  3. Angewandte Chemie (International ed. in English). 2024, Dec 18; e202417651.
  1. 2.   Stealth oxime ether lipid vesicles promote delivery of functional DsiRNA in human lung cancer A549 tumor bearing mouse xenografts
  2. Puri,Anu; Ibrahim, Faisal; O'Reilly Beringhs, André; Isemann, Camryn; Zakrevsky, Paul; Whittenburg, Abigail; Hargrove, Derek; Kanai,Tapan; Dillard, Rebecca S; de Val, Natalia; Nantz, Michael H; Lu, Xiuling; Shapiro,Bruce
  3. Nanomedicine : nanotechnology, biology, and medicine. 2022, Jun 04; 102572.
  1. 3.   The quaternary assembly of KRas4B with Raf-1 at the membrane
  2. Jang,Hyunbum; Zhang,Mingzhen; Nussinov,Ruth
  3. Computational and Structural Biotechnology Journal. 2020, Mar 25; 18: 737-748.
  1. 4.   LC-MS/MS assay coupled with carboxylic acid magnetic bead affinity capture to quantitatively measure cationic host defense peptides (HDPs) in complex matrices with application to preclinical pharmacokinetic studies
  2. O'Neill,Maura; Chan,King; Jaynes, Jesse M; Knotts, Zachary; Xu,Xia; Abisoye-Ogunniyan, Abisola; Guerin,Theresa; Schlomer,Jerome; Li, Dandan; Cary, Jeffrey W; Rajasekaran, Kanniah; Yates, Clayton; Kozlov,Serguei; Andresson,Thorkell; Rudloff, Udo
  3. Journal of pharmaceutical and biomedical analysis. 2020, Mar 20; 181: 113093.
  1. 5.   Raf-1 Cysteine-Rich Domain Increases the Affinity of K-Ras/Raf at the Membrane, Promoting MAPK Signaling
  2. Li, Shuai; Jang, Hyunbum; Zhang, Jian; Nussinov, Ruth
  3. Structure . 2018, Mar 6; 26(3): 513-+.
  1. 6.   BRCA1 regulation on beta-hCG: a mechanism for tumorigenicity in BRCA1 defective breast cancer
  2. Sengodan, S. K.; Nadhan, R.; Nair, R. S.; Hemalatha, S. K.; Somasundaram, Veena; Sushama, R. R.; Rajan, A.; Latha, N. R.; Varghese, G. R.; Thankappan, R. K.; Kumar, J. M.; Chil, A.; Anilkumar, T. V.; Srinivas, P.
  3. ONCOGENESIS. 2017, SEP; 6
  1. 7.   Ionic Liquids: Neoteric Solvents for Nucleoside Chemistry
  2. Kumar, V.; Parmar, V. S.; Malhotra, S. V.
  3. Current Organic Synthesis. 2011, Dec; 8(6): 777-786.
  1. 9.   Hofmeister Series Salts Enhance Purification of Plasmid DNA by Non-Ionic Detergents
  2. Lezin, G.; Kuehn, M. R.; Brunelli, L.
  3. Biotechnology and Bioengineering. 2011, Aug; 108(8): 1872-1882.
  1. 10.   O-Glycosidation reactions promoted by in situ generated silver N-heterocyclic carbenes in ionic liquids
  2. Talisman, I. J.; Kumar, V.; Razzaghy, J.; Malhotra, S. V.
  3. Carbohydrate Research. 2011, May; 346(7): 883-890.
  1. 11.   Biological evaluation of imidazolium- and ammonium-based salts as HIV-1 integrase inhibitors
  2. Maddali, K.; Kumar, V.; March, C.; Pommier, Y.; Malhotra, S. V.
  3. Medchemcomm. 2011, Feb; 2(2): 143-150.
  1. 12.   Structural modifications of nucleosides in ionic liquids
  2. Kumar, V.; Parmar, V. S.; Malhotra, S. V.
  3. Biochimie. 2010, Sep; 92(9): 1260-1265.
  1. 13.   Application of Halide Molten Salts as Novel Reaction Media for O-Glycosidic Bond Formation
  2. Kumar, V.; Talisman, I. J.; Malhotra, S. V.
  3. European Journal of Organic Chemistry. 2010, Jun; (18): 3377-3381.
  1. 14.   Arylation of Sensitive 1-(Pyrrolidin-1-yl)-diazen-1-ium-diolate in Ionic Liquids
  2. Velazquez, C. A.; Lynn, G. M.; Kumar, V.; Keefer, L. K.; Malhotra, S. V.
  3. Synthetic Communications. 2010, Apr 7; 40(9): 1322-1332.
  1. 15.   The mechanism responsible for the supraphysiologic gonadotropin surge in females treated with gonadotropin-releasing hormone (GnRH) agonist and primed with GnRH antagonist
  2. Taylor, J. E.; Miller, B. T.; Gray, K. D.; Scott, R. T.; Catherino, W. H.; Segars, J. H.
  3. Fertility and Sterility. 2010, Mar; 93(5): 1668-1675.
  1. 16.   A profile of the in vitro anti-tumor activity of imidazolium-based ionic liquids
  2. Malhotra, S. V.; Kumar, V.
  3. Bioorganic & Medicinal Chemistry Letters. 2010, Jan; 20(2): 581-585.
  1. 17.   Misfolded amyloid ion channels present mobile beta-sheet subunits in contrast to conventional ion channels
  2. Jang, H.; Arce, F. T.; Capone, R.; Ramachandran, S.; Lal, R.; Nussinov, R.
  3. Biophysical Journal. 2009, Dec 2; 97(11): 3029-37.
  1. 18.   Highly Efficient Method for C-5 Halogenation of Pyrimidine-Based Nucleosides in Ionic Liquids
  2. Kumar, V.; Yap, J.; Muroyama, A.; Malhotra, S. V.
  3. Synthesis-Stuttgart. 2009, Dec; (23): 3957-3962.
  1. 19.   Ionic liquid mediated synthesis of 5-halouracil nucleosides: key precursors for potential antiviral drugs
  2. Kumar, V.; Malhotra, S. V.
  3. Nucleosides, nucleotides & nucleic acids. 2009, Sep; 28(9): 821-34.
  1. 20.   Study on the potential anti-cancer activity of phosphonium and ammonium-based ionic liquids
  2. Kumar, V.; Malhotra, S. V.
  3. Bioorganic & Medicinal Chemistry Letters. 2009 19(16): 4643-4646.
  1. 22.   Synthesis of nucleoside-based antiviral drugs in ionic liquids
  2. Kumar, V.; Malhotra, S. V.
  3. Bioorganic & Medicinal Chemistry Letters. 2008 18(20): 5640-5642.
  1. 23.   FeCl3-catalyzed Pechmann synthesis of coumarins in ionic liquids
  2. Kumar, V.; Tomar, S.; Patel, R.; Yousaf, A.; Parmar, V. S.; Malhotra, S. V.
  3. Synthetic Communications. 2008 38(15): 2646-2654.
  1. 24.   Human defensins: synthesis and structural properties
  2. Pazgier, M.; Li, X.; Lu, W.; Lubkowski, J.
  3. Current Pharmaceutical Design. 2007 13(30): 3096-3118.
  1. 25.   Defensin participation in innate and adaptive immunity
  2. Yang, D.; Liu, Z. H.; Tewary, P.; Chen, Q.; De la Rosa, G.; Oppenheim, J. J.
  3. Current Pharmaceutical Design. 2007 13(30): 3131-3139.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel